Skip to main content
OXFORD BIODYNAMICS PLC logo

OXFORD BIODYNAMICS PLC — Investor Relations & Filings

Ticker · OBD ISIN · GB00BD5H8572 LEI · 2138005Y1TK258O5U928 IL Professional, scientific and technical activities
Open in API
Filings indexed 416 across all filing types
Latest filing 2025-01-14 Capital/Financing Update
Country GB United Kingdom
Listing IL OBD

About OXFORD BIODYNAMICS PLC

https://www.oxfordbiodynamics.com/

Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests. The company's proprietary EpiSwitch® platform utilizes 3D genomics and epigenetic biomarkers to create diagnostic solutions for life-changing diseases, with a focus on oncology. Its portfolio of clinical tests includes the EpiSwitch® PSE, a blood test that assesses the likelihood of prostate cancer with high accuracy to help reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test designed to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. The platform enables the translation of 3D genome regulation into clinical applications for precision medicine at scale.

Recent filings

Filing Released Lang Actions
WRAP Retail Offer
Capital/Financing Update Classification · 98% confidence The document is an official announcement released via RNS (RNS Number : 3172T) on January 14, 2025. The content details a proposed fundraising activity involving a 'WRAP Retail Offer' and a 'Placing and Subscriptions' to raise capital (£500,000 and not less than £6 million, respectively) through the issue of new ordinary shares. This clearly falls under the category of company financing activities. The definition for 'Capital/Financing Update' (CAP) is 'Updates on company fundraising, financing activities, or capital structure changes.' Although it is a formal announcement, the core subject matter is the financing event itself, making CAP a more specific fit than the general 'RNS' fallback. Since the document is a detailed announcement of the terms of the fundraising, it is classified as CAP.
2025-01-14 English
Proposed Fundraising
Capital/Financing Update Classification · 98% confidence The document is an RNS announcement dated 14 January 2025 from Oxford BioDynamics PLC. The title explicitly mentions a 'Proposed Fundraising' (Placing, Subscriptions, WRAP Offer) and a 'Notice of General Meeting'. The text details the terms of the fundraising, the Issue Price, the intended use of proceeds, and the requirement for shareholder approval via Resolutions at a General Meeting. This content strongly indicates an announcement related to raising capital and seeking shareholder approval for that capital change. Since it is an announcement detailing a proposed share issue/fundraising that requires shareholder approval (via a General Meeting), it fits best under Capital/Financing Update (CAP). While it mentions a General Meeting, the primary focus is the fundraising mechanism itself, not just the voting results (DVA) or the proxy materials (PSI). It is a formal announcement of a significant financing event.
2025-01-14 English
Issue of shares, Director / PDMR holdings and TVR
Remuneration Information Classification · 99% confidence The document is an RNS announcement (RNS Number: 2011R) dated December 24, 2024, detailing the 'Issue of shares in lieu of salary, Director / PDMR shareholdings & Total voting rights'. It specifically reports transactions by Persons Discharging Managerial Responsibilities (PDMRs) and directors, including the number of shares issued and the resulting shareholdings. This content directly aligns with the definition of Director's Dealing (insider trades) and also touches upon share issuance by insiders. The most specific category covering director/insider transactions is 'Director's Dealing' (DIRS). While it involves share issuance (SHA/POS), the primary focus and regulatory context provided (Market Abuse Regulation disclosure) point strongly to DIRS.
2024-12-24 English
Shareholder Loan and Related Party Transaction
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number (8134Q) and the standard footer indicating it is provided by RNS, the news service of the London Stock Exchange, which is approved by the FCA as a Primary Information Provider. The content details a specific corporate action: entering into a shareholder loan agreement with a related party (Vulpes Testudo Fund) and notes that this constitutes a related party transaction under AIM Rule 13. This type of announcement—a material, non-financial corporate event disclosure made via an official regulatory news service—fits best under the general 'Regulatory Filings' category, as it is not an Earnings Release (ER), Interim Report (IR), Annual Report (10-K), or a specific transaction like Director's Dealing (DIRS) or Share Repurchase (POS). Since it is a general regulatory announcement distributed through RNS, the most appropriate code is RNS.
2024-12-19 English
Directorate Change, Funding Update & Joint Broker
Regulatory Filings Classification · 98% confidence The document is identified by the header 'RNS Number : 1943Q' and the closing statement referencing 'RNS, the news service of the London Stock Exchange.' This indicates it is a regulatory announcement. The content details significant corporate actions: the resignation of the CEO, the planned appointment of an Executive Chairman contingent on a fundraise, and an update on a potential equity fundraise (£4m) and the appointment of a joint broker. These topics—Board Changes, Update on Funding, and Appointment of Joint Broker—are material events that require immediate disclosure to the market. Since this is a direct announcement of material corporate events rather than a full periodic report (like 10-K or IR) or a presentation (like IP), and it is distributed via the RNS system, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such immediate disclosures that don't fit a more specific operational category like DIV or DIRS. It is not an RPA because it contains the full substance of the news, not just an announcement that a report is available.
2024-12-16 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 2109P' and contains the standard format for 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the classification over the general RNS fallback.
2024-12-06 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.